# Addex Therapeutics Ltd American Depositary Shares (ADXN)

> Addex Therapeutics Ltd American Depositary Shares (ADXN) trades at $4.78 (+65.40%) as of 6:47:56 AM EST on Nov 12, 2026, -4.93% over the past month. Market cap is $5.06M, with 1.6 days to cover in short interest.

Canonical: https://massive.com/quote/adxn
Data as of: 2026-11-12T11:47:56.746Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$4.78** +1.89 (+65.40%)
As of 6:47:56 AM EST on Nov 12, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Addex Therapeutics Ltd American Depositary Shares (ADXN) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +3.58% |
| 1W | -3.83% |
| 1M | -4.93% |
| YTD | -62.56% |
| 1Y | -66.40% |
| 52-wk range | $2.56 – $10.43 |

From daily closes through Nov 10, 2026.

## Key statistics

Today's trading snapshot for ADXN: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | — |
| Open | — |
| Prev close | $2.89 |
| Volume | 3.15M |
| Market cap | $5.06M |
| Shares out | 2.6M |

## Insider trading

[Addex Therapeutics Ltd American Depositary Shares (ADXN) insider trading](https://massive.com/quote/adxn/insider-trading.md): open-market Form 4 buys and sells by Addex Therapeutics Ltd American Depositary Shares insiders over the last 12 months.

## Dividend history and stock splits

Addex Therapeutics Ltd American Depositary Shares's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-20 · Oct 23, 2023

## ADXN short interest

How heavily ADXN is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.6 |
| Short interest | 5.97K |
| Avg volume | 3.75K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## ADXN news

The latest news and headlines about Addex Therapeutics Ltd American Depositary Shares (ADXN).

- [Addex Spin-out Neurosterix Closes $105 Million Series B Financing](https://www.globenewswire.com/news-release/2026/11/11/3401151/0/en/addex-spin-out-neurosterix-closes-105-million-series-b-financing.html) · GlobeNewswire Inc. · Nov 11, 2026 · positive sentiment
- [ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES](https://www.globenewswire.com/news-release/2026/10/29/3390910/0/en/addex-increases-issued-share-capital-to-create-treasury-shares.html) · GlobeNewswire Inc. · Oct 29, 2026 · neutral sentiment
- [Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders](https://www.globenewswire.com/news-release/2025/06/30/3107133/0/en/Addex-Leads-CHF-2-Million-Investment-in-Stalicla-to-Advance-Precision-Medicine-in-Neuropsychiatric-Disorders.html) · GlobeNewswire Inc. · Jun 30, 2025 · positive sentiment
- [Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs](https://www.globenewswire.com/news-release/2025/06/30/3107134/0/en/Stalicla-Secures-CHF-2-Million-Financing-Led-by-Addex-Therapeutics-to-Advance-Precision-Medicine-Neurodevelopmental-Disorder-Programs.html) · GlobeNewswire Inc. · Jun 30, 2025 · positive sentiment
- [Addex Shareholders Approve All Resolutions at Annual General Meeting](https://www.globenewswire.com/news-release/2025/06/25/3104791/0/en/Addex-Shareholders-Approve-All-Resolutions-at-Annual-General-Meeting.html) · GlobeNewswire Inc. · Jun 25, 2025 · positive sentiment

## About Addex Therapeutics Ltd American Depositary Shares

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | ADRC |
| Currency | USD |
| Employees | 3 |
| Listed | Jan 29, 2020 |

[Company website](https://www.addextherapeutics.com)

## FAQ

### What is the Addex Therapeutics Ltd American Depositary Shares (ADXN) stock price today?

Addex Therapeutics Ltd American Depositary Shares (ADXN) is trading at $4.78 (+65.40% on the day) as of 6:47:56 AM EST on Nov 12, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Addex Therapeutics Ltd American Depositary Shares?

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators.

### What is the short interest in ADXN?

As of Oct 30, 2026, ADXN has 5.97K shares short and 1.6 days to cover.

### What exchange is ADXN listed on?

Addex Therapeutics Ltd American Depositary Shares (ADXN) trades on Nasdaq in USD.

## Live data

Prices here are 15-minute delayed. For real-time ADXN quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ADXN`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Addex Therapeutics Ltd American Depositary Shares (ADXN) insider trading](https://massive.com/quote/adxn/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms